Head and neck cancer
Dose Escalation Using Hypoxia-adjusted Radiotherapy
Who can joinAdults
Age18–70 years
Kind of studyPhase 2: does it work?
What it testsRadiation and a medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
1 hospital in India taking patients for this trial.
Rajiv Gandhi Cancer Institute and Research CentreDelhiDirections ↗
Registry summary (technical)
DE-HyART is a phase II clinical trial aimed at understanding the effects of escalating radiation doses to hypoxic sub-volumes inherent to squamous cell head and neck cancer. The study is aimed at assessing locoregional control, feasibility, and acceptable toxicity with such a strategy.
Sponsor: Rajiv Gandhi Cancer Institute & Research Center, India
NCT06087614 on ClinicalTrials.gov
Last updated on the registry 17 Jan 2025 · read by us 20 Oct 2026